Latest papers

Results for “transfusion cardiac restrictive OR transfusion cardiac liberal”.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Review Blood Transfus Published 28 Oct 2026
Perioperative hemostatic therapy in adult cardiac surgery: a narrative review highlighting human factors.
AI-generated abstract summary · verify against the original paper
  • This narrative review synthesizes fourteen original studies covering nearly 220,000 patients from over 1,000 centres worldwide.
  • It focuses on platelet concentrate and fresh frozen plasma use in adult cardiac surgery and how hemostatic therapy varies between centres.
  • Platelet and plasma transfusion rates differed significantly across centres, and patient and procedural characteristics do not fully explain these differences.
  • Viscoelastic tests have improved assessment in some settings but have not eliminated variation, which the authors attribute partly to hospital culture, organization, thresholds and human factors.
PubMed indexed 2 Nov 2026 Imported 9 Nov 2026 Sebestyen A et al. Publisher CardiacPerioperative medicine
Review Blood Transfus Published 14 Oct 2026
From liberal to restrictive and beyond: a narrative review of red blood cell transfusion strategies in the modern era.
AI-generated abstract summary · verify against the original paper
  • This narrative review of red blood cell transfusion thresholds draws on 2021–2026 trials, meta-analyses, and guidelines identified through PubMed and Google Scholar searches.
  • It compares restrictive (Hb 7–8 g/dL) and liberal (Hb above 10 g/dL) strategies, then considers population-specific exceptions and ultra-restrictive thresholds (Hb <6–7 g/dL).
  • The 2025 Cochrane update (48 trials, >20,000 participants) reported that restrictive strategies reduced the proportion receiving at least one transfusion by 41%, without increasing 30-day mortality or major morbidity.
  • Restrictive thresholds appear safe in stable critically ill patients, non-cardiac surgery, and acute GI bleeding, while acute MI, neurocritical care, thalassemia, and hematologic malignancies need individualized approaches.
PubMed indexed 2 Nov 2026 Imported 9 Nov 2026 Koutoulogeni A et al. Publisher Perioperative medicine
Review Heart Lung Circ Published 19 Jun 2026
Coagulopathy in Cardiac Surgery: A Scoping Review of Prothrombin Complex Concentrate.
AI-generated abstract summary · verify against the original paper
  • This scoping review (PRISMA-ScR) mapped 57 primary studies and 15 reviews on 4-factor PCC in adults undergoing on-pump cardiac surgery.
  • The comparator was FFP, and reported PCC dosing ranged from fixed 500-4000 IU to weight-based 15-30 IU/kg.
  • Evidence consistently suggests PCC reduces chest tube output and transfusion versus FFP, though effect sizes vary; no pooled estimates are reported.
  • The authors conclude that gaps remain on optimal dose, timing, viscoelastic targets, and fibrinogen sequencing, with limited cost-effectiveness data and rare serious adverse events.
PubMed indexed 19 Jun 2026 Imported 9 Nov 2026 Vander Zwaag S et al. Publisher CardiacPerioperative medicine